{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:45:52Z","timestamp":1775699152846,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcjo.2025.08.011","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:51:08Z","timestamp":1757627468000},"page":"393-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of oral belzutifan on retinal hemangioblastomas in von Hippel\u2013Lindau syndrome"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7462-7725","authenticated-orcid":false,"given":"Kirk A.J.","family":"Stephenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-1085","authenticated-orcid":false,"given":"Jennifer Y.M.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2527-481X","authenticated-orcid":false,"given":"Olubayo U.","family":"Kolawole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"O\u2019Loughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lica","family":"Chui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-0460","authenticated-orcid":false,"given":"Cheryl Y.","family":"Gregory-Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Gregory-Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick E.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2025.08.011_bib0001","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1167\/iovs.10-5223","article-title":"Genotype-phenotype correlation in ocular von Hippel\u2013Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype","volume":"51","author":"Mettu","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0002","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","article-title":"Management of retinal hemangioblastoma in von Hippel\u2013Lindau disease","volume":"39","author":"Wiley","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0003","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel\u2013Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0004","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/IAE.0000000000003973","article-title":"Successful treatment response of a juxtapapillary retinal capillary hemangioblastoma due to von Hippel\u2013Lindau with belzutifan in a pediatric patient","volume":"44","author":"Mustafi","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/ICB.0000000000001516","article-title":"Belzutifan for treatment of giant retinal hemangioblastoma with extrascleral extension associated with von Hippel\u2013Lindau syndrome","volume":"19","author":"Cotton","year":"2025","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0006","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICB.0000000000001376","article-title":"Two cases of von Hippel\u2013Lindau syndrome-associated retinal hemangioblastoma treated with belzutifan","volume":"18","author":"Grimes","year":"2024","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0007","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ophtha.2024.05.024","article-title":"Oral HIF-2\u03b1 inhibitor belzutifan in ocular von Hippel\u2013Lindau disease: subgroup analysis of the single-arm phase 2 LITESPARK-004 study","volume":"131","author":"Wiley","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0008","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1016\/j.jcjo.2024.05.025","article-title":"Belzutifan as the first-line treatment for a challenging von Hippel\u2013Lindau-related retinal hemangioblastoma: successful treatment of a case and review of the literature","volume":"59","author":"Aykut","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0009","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/24741264241309684","article-title":"Belzutifan as the primary treatment of bilateral juxtapapillary retinal hemangioblastoma in a patient with von Hippel\u2013Lindau disease","volume":"9","author":"Dameron","year":"2024","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31371","article-title":"Pediatric patients with von Hippel\u2013Lindau and hemangioblastomas treated successfully with belzutifan","volume":"72","author":"Duan","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0011","article-title":"Belzutifan-induced regression of retinal capillary hemangioblastoma: a case-series","volume":"33","author":"Ercanbrack","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0012","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ophtha.2022.07.007","article-title":"Systemic treatment reduces Von-Hippel\u2013Lindau-associated retinal capillary hemangioblastoma","volume":"130","author":"Fairbanks","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0013","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000539434","article-title":"Belzutifan in individuals with von Hippel\u2013Lindau retinal hemangioblastomas: institutional experience and review of the literature","volume":"10","author":"Jamshidi","year":"2024","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0014","doi-asserted-by":"crossref","unstructured":"Meade J, Nischal K, Olsen KR. Response of a von Hippel\u2013Lindau-associated optic nerve hemangioblastoma to belzutifan. Retin Cases Brief Rep 2024 May 24. doi:10.1097\/icb.0000000000001606. Online ahead of print.","DOI":"10.1097\/ICB.0000000000001606"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3928\/23258160-20240607-01","article-title":"Significant improvement in retinal capillary hemangioblastoma with belzutifan","volume":"55","author":"Mohammadi","year":"2024","journal-title":"Ophthal Surg Lasers Imag Retina"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0016","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/ICB.0000000000001452","article-title":"Successful treatment of Von Hippel\u2013Lindau (VHL) disease-associated retinal capillary hemangioblastoma (RCH) with belzutifan in a pediatric patient","volume":"18","author":"Jones","year":"2024","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0017","first-page":"B4763","article-title":"Von Hippel\u2013Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition","volume":"60","author":"Binderup","year":"2013","journal-title":"Dan Med J"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0018","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","article-title":"Lindau\u2019s disease. Review of the literature and study of a large kindred","volume":"36","author":"Melmon","year":"1964","journal-title":"Am J Med"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/cge.13613","article-title":"Comprehensive characterization of a Canadian cohort of von Hippel\u2013Lindau disease patients","volume":"96","author":"Salama","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0020","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3390\/genes13112122","article-title":"Tumorigenesis mechanisms found in hereditary renal cell carcinoma: a review","volume":"13","author":"Webster","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fonc.2016.00068","article-title":"Heritable cancer syndromes related to the hypoxia pathway","volume":"6","author":"Henegan","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/ICU.0b013e3282fb7c04","article-title":"Ocular von Hippel\u2013Lindau disease: clinical update and emerging treatments","volume":"19","author":"Wong","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/13816810.2014.886265","article-title":"Genotype-phenotype correlations, and retinal function and structure in von Hippel\u2013Lindau disease","volume":"35","author":"Wittstr\u00f6m","year":"2014","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0024","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel\u2013Lindau disease: a clinical and molecular study","volume":"43","author":"Dollfus","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.oret.2021.08.005","article-title":"Intrafamilial variability of ocular manifestations of von Hippel\u2013Lindau disease","volume":"6","author":"Bowen","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0026","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","article-title":"von Hippel\u2013Lindau disease","volume":"46","author":"Singh","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0027","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel\u2013Lindau disease","volume":"120","author":"Lonser","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0028","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel\u2013Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0029","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ophtha.2008.04.033","article-title":"Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel\u2013Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0030","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13301","article-title":"Sunitinib for the treatment of benign and malignant neoplasms from von Hippel\u2013Lindau disease: a single-arm, prospective phase II clinical study from the PREDIR group","volume":"7","author":"Oudard","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0031","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13023-017-0664-7","article-title":"Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel\u2013Lindau disease","volume":"12","author":"Albi\u00f1ana","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0032","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","article-title":"Clinical characteristics of ocular angiomatosis in von Hippel\u2013Lindau disease and correlation with germline mutation","volume":"117","author":"Webster","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0033","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1167\/iovs.03-0282","article-title":"Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel\u2013Lindau tumor-suppressor gene in vivo","volume":"45","author":"Akiyama","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0034","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ceb.2007.02.003","article-title":"Hypoxia signalling controls metabolic demand","volume":"19","author":"Brahimi-Horn","year":"2007","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.iae.0000244659.62202.ee","article-title":"Molecular pathology of eyes with von Hippel\u2013Lindau (VHL) Disease: a review","volume":"27","author":"Chan","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0037","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162480","article-title":"Von Hippel\u2013Lindau disease: insights into oxygen sensing, protein degradation, and cancer","volume":"132","author":"Kaelin","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0038","article-title":"Oral HIF-2\u03b1 inhibitor belzutifan for ocular von Hippel\u2013Lindau (VHL) disease","volume":"62","author":"Wiley","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0039","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/ICB.0000000000001452","article-title":"Successful treatment of von Hippel\u2013Lindau disease-associated retinal capillary hemangioblastoma with belzutifan in a pediatric patient","volume":"18","author":"Jones","year":"2024","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0040","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(24)00389-9","article-title":"Belzutifan for patients with von Hippel\u2013Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study","volume":"25","author":"Iliopoulos","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcjo.2025.08.011_bib0041","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.cdd.4402313","article-title":"The VHL tumor suppressor and HIF: insights from genetic studies in mice","volume":"15","author":"Kapitsinou","year":"2008","journal-title":"Cell Death Differ"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:49:41Z","timestamp":1775695781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418225003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0008418225003709"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.08.011","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of oral belzutifan on retinal hemangioblastomas in von Hippel\u2013Lindau syndrome","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}